{"id":"https://openalex.org/A5073779622","orcid":"https://orcid.org/0009-0008-4413-8569","observed_orcids":["https://orcid.org/0009-0008-4413-8569"],"display_name":"Abigail Titus","raw_author_names":["Abigail Titus"],"full_name":"Abigail Titus","works_count":3,"cited_by_count":0,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":0,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5073779622","orcid":"https://orcid.org/0009-0008-4413-8569","observed_orcids":["https://orcid.org/0009-0008-4413-8569"]},"affiliations":[{"institution":{"id":"https://openalex.org/I26092322","ror":"https://ror.org/05bk57929","display_name":"Stellenbosch University","country_code":"ZA","type":"education","lineage":["https://openalex.org/I26092322"]},"years":[2022]},{"institution":{"id":"https://openalex.org/I32971472","ror":"https://ror.org/03v76x132","display_name":"Yale University","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]},"years":[2026]}],"last_known_institutions":[{"id":"https://openalex.org/I32971472","ror":"https://ror.org/03v76x132","display_name":"Yale University","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","count":2,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","count":2,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","count":2,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12027","display_name":"Social Media in Health Education","count":1,"subfield":{"id":"https://openalex.org/subfields/3306","display_name":"Health"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12413","display_name":"Health and Medical Education","count":1,"subfield":{"id":"https://openalex.org/subfields/3600","display_name":"General Health Professions"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T14240","display_name":"E-Learning and COVID-19","value":1.86e-05,"subfield":{"id":"https://openalex.org/subfields/3304","display_name":"Education"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12027","display_name":"Social Media in Health Education","value":1.27e-05,"subfield":{"id":"https://openalex.org/subfields/3306","display_name":"Health"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","value":6.4e-06,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","value":6e-06,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","value":5.5e-06,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9331027865409851},{"id":"2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","score":0.8909502029418945},{"id":"2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","score":0.6833792328834534},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.6401243209838867},{"id":"17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","score":0.5791612267494202}],"counts_by_year":[{"year":2021,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2022,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":0}],"display_name_alternatives":["Abigail Titus"],"block_key":"a titus","works_api_url":"https://api.openalex.org/works?filter=author.id:A5073779622","updated_date":"2026-10-10T12:59:14","created_date":"2025-10-10T00:00:00"}